Cost-effectiveness of Innovations - How to Evaluate New Therapies
This article discusses the importance of evaluating the cost-effectiveness of innovative therapies in healthcare, particularly in light of new drug developments.
With a Vision of Prevention and Innovation: The New Era of GSK in Greece
GSK Greece is focusing on enhancing access to vaccines and innovative therapies as it aims to establish Greece as a clinical research hub, according to its President and General Director Lizzie Champion.
Why is the wait for innovative cancer drugs particularly long in Korea?
Despite advancements in cancer treatment technologies, South Korean patients face significantly longer wait times for new cancer drugs compared to other developed countries.
When standard treatment no longer helps: advanced cancer diagnostics and treatment at Kaunas Clinics
The Kaunas Clinics have launched a Nuclear Medicine Research Center, offering modern treatments for advanced cancer through precision medicine and innovative therapies.
VIANEX and Johnson & Johnson renew their partnership
Johnson & Johnson and VIANEX Group have renewed and expanded their strategic partnership to enhance Greek patients' access to innovative therapies with new distribution agreements.